本文選題：腦梗死 + 心律失常�。� 參考：《中國現(xiàn)代醫(yī)學雜志》2017年10期

【摘要】：目的分析影響腦梗死患者伴發(fā)心律失常-房顫的危險因素,以期改善腦梗死患者預后。方法回顧性調查統(tǒng)計南陽市中心醫(yī)院2014年1月-2015年10月收治的96例腦梗死患者的臨床資料,其中腦梗死后伴發(fā)心律失常-房顫的患者共有23例,記為觀察組;其余73例未發(fā)生心律失常-房顫的患者記為對照組。對兩組可能影響心率失常-房顫發(fā)生的因素分別采用單因素兩樣本比較和多因素Logistic回歸分析方法確定其影響因素,以期為臨床腦梗死患者預后改善提供依據(jù)。結果年齡≥70歲、心律失常-房顫家族史、大面積腦梗死、NIHSS評分≥16分、合并高血壓、合并糖尿病、心功能Ⅲ~Ⅳ級、抗凝治療、服用溶栓藥物、腦梗死手術治療、LAD≥45 mm、LEVDD≥50 mm、頸動脈軟斑塊、適當鍛煉等均是腦梗死患者伴發(fā)心律失常-房顫的影響因素(P0.05);多因素Logistic回歸分析發(fā)現(xiàn),影響腦梗死患者伴發(fā)心律失常-房顫的危險因素按照危險程度由高到低排列為大面積腦梗死(OR=3.987)、頸動脈軟斑塊(OR=3.246)、NIHSS評分≥16分(OR=3.214)、合并高血壓(OR=2.067)、年齡≥70歲(OR=1.932),而抗凝治療、服用溶栓藥物、腦梗死手術治療、適當鍛煉均是腦梗死患者伴發(fā)心律失常-房顫的保護性因素(b0,0OR1,P0.05)。結論影響腦梗死患者伴發(fā)心率失常-房顫的危險因素多種多樣,臨床上應針對大面積腦梗死、頸動脈軟斑塊、NIHSS評分≥16分、合并高血壓的患者加強防范,同時給予抗血小板聚集、溶栓類藥物和適當鍛煉指導,降低心律失常-房顫發(fā)生率。
[Abstract]:Objective to analyze the risk factors of arrhythmia and atrial fibrillation in patients with cerebral infarction, and to improve the prognosis of patients with cerebral infarction. Methods the clinical data of 96 patients with cerebral infarction treated in Nanyang Central Hospital from January 2014 to October 2015 were retrospectively analyzed. 23 patients with arrhythmia and atrial fibrillation after cerebral infarction were recorded as observation group. The remaining 73 patients without arrhythmia-atrial fibrillation were recorded as control group. Univariate comparison of two samples and multivariate Logistic regression analysis were used to determine the influencing factors of the two groups of possible factors affecting the occurrence of arrhythmia and atrial fibrillation in order to provide evidence for the improvement of prognosis of the patients with clinical cerebral infarction. Results Age 鈮，

本文編號：1974372